Search

Your search keyword '"Bonavita, Simona"' showing total 520 results

Search Constraints

Start Over You searched for: Author "Bonavita, Simona" Remove constraint Author: "Bonavita, Simona" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
520 results on '"Bonavita, Simona"'

Search Results

2. ChatGPT vs. neurologists: a cross-sectional study investigating preference, satisfaction ratings and perceived empathy in responses among people living with multiple sclerosis

5. Signs and symptoms of COVID‐19 in patients with multiple sclerosis

7. Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

8. NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab

9. The effect of air pollution on COVID‐19 severity in a sample of patients with multiple sclerosis

13. Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals’ perspective

14. Health related quality of life in the domain of physical activity predicts confirmed disability progression in people with relapsing remitting multiple sclerosis

17. Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic

18. Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study

20. Sex effects across the lifespan in women with multiple sclerosis

22. Telemedicine application to headache: a critical review

28. PML risk is the main factor driving the choice of discontinuing natalizumab in a large multiple sclerosis population: results from an Italian multicenter retrospective study

29. Disability assessment using Google Maps

36. MRI activity and extended interval of Natalizumab dosing regimen: a multicentre Italian study

40. Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy: a Multicentre Comparison Study

42. Impact of COVID-19 on pregnancy and fetal outcomes in women with multiple sclerosis.

45. Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders

46. Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod

47. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context

48. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?

Catalog

Books, media, physical & digital resources